Women are Preparing for Potential Abortion Restrictions Under Trump

With the election of Donald Trump, women across the United States are increasingly obtaining abortion medications and Plan B, driven by fear of potential new legislative obstacles.

Telehealth Providers Experience Surge in Demand

As Americans absorbed the news of Trump’s victory, Dr. Angel Foster realized her workload was about to significantly escalate. Foster is a co-founder of the Massachusetts Medication Abortion Access Project (MAP), a telehealth service distributing abortion pills nationwide, even to prohibited locations.

On a typical day, around 130 to 140 individuals initiate contact with MAP. However, after the election, inquiries soared to over 1,000. This spike reflects a mix of pregnant women and those purchasing for possible future use.

Concerns About Future Restrictions

Foster’s organization is not alone; similar patterns were reported by Aid Access, Hey Jane, and Wisp. They observed significant increases in orders for abortive medications. Despite Trump’s assurances, the use of executive power to restrict access remains a looming possibility, particularly targeting the widely used two-pill abortion regimen.

Brittany Fonteno, National Abortion Federation president, believes heightened fears are rooted in the memory of Trump’s prior term. Concerns focus on potential measures against telehealth abortions, the prescription process, and postal services for abortion pills. Legal challenges to these actions seem probable, given the current Supreme Court’s conservative stance.

Policy Decisions and Legal Implications

The Trump administration’s influence is poised to reshape federal abortion policy, largely through bodies like the Department of Justice or the Department of Health and Human Services. Notably, Trump’s nominees for attorney general and health secretary have starkly different views on abortion, introducing uncertainty about future regulations.

Specifically, Trump's suggestion to nominate Rep. Matt Gaetz, an abortion opponent, for attorney general could catalyze enforcement of historic anti-abortion laws. Conversely, nominating Robert F. Kennedy Jr., who upholds abortion rights, to lead Health and Human Services, could lead to friction in policy-making.

Impact of Recent Policy Changes and Current Demand

The Biden administration’s policy adjustment to facilitate prescription and distribution of abortion medication via telehealth has enhanced access, particularly benefiting underserved regions. A notable rise in abortion numbers from 2020 to 2023 documented by supportive think tanks underscores this expansion.

Anti-abortion advocates, such as those in Susan B. Anthony Pro-Life America, view this growth as a threat. Their objective centers on reversing policies introduced during the Biden-Harris tenure.

Uncertain Future and Proactive Measures

Despite having various avenues to restrict abortion access, Donald Trump has yet to clarify his specific plans or timeline. The legal ramifications of any new strategies remain uncertain.

Meanwhile, proactive measures are being taken by women, who see a contentious future ahead. Along with increased abortion pill requests, demand for emergency contraception, like Plan B, has also surged as women assert control over their reproductive health.

Wisp’s CEO, Monica Cepak, notes this heightened demand for emergency contraception echoes the response seen when prior legal decisions sparked uncertainty in reproductive rights.